Bivalent (Omicron BA.5/ancestral) recombinant spike protein vaccine: a promising booster.

Zhang, Ruiqi; Hung, Ivan Fan-Ngai

Zhang, Ruiqi; Hung, Ivan Fan-Ngai.

Affiliation

Zhang R; Department of Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, Special Administration Region, China.
Hung IF; Department of Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, Special Administration Region, China. Electronic address: ivanhung@hku.hk.

Lancet Infect Dis ; 24(6): 558-559, 2024 Jun.

Article in En | MEDLINE | ID: mdl-38460526

Subject(s)

COVID-19 Vaccines; COVID-19; Immunization, Secondary; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Vaccines, Synthetic; Humans; COVID-19 Vaccines/immunology; COVID-19 Vaccines/administration & dosage; Spike Glycoprotein, Coronavirus/immunology; Spike Glycoprotein, Coronavirus/genetics; Vaccines, Synthetic/administration & dosage; Vaccines, Synthetic/immunology; SARS-CoV-2/immunology; COVID-19/prevention & control; Antibodies, Viral/blood; Antibodies, Viral/immunology

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Vaccines, Synthetic / Immunization, Secondary / Spike Glycoprotein, Coronavirus / COVID-19 Vaccines / SARS-CoV-2 / COVID-19 Limits: Humans Language: En Journal: Lancet Infect Dis Journal subject: DOENCAS TRANSMISSIVEIS Year: 2024 Document type: Article Affiliation country: China

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google